Most Read Articles
4 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

2 days ago
Susceptibility‐guided therapy is as effective as empiric modified bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection, with both yielding excellent eradication rates, as shown in a recent trial.
4 days ago
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
2 days ago
The risk factors and outcomes associated with an increased risk of permanent pacing include atrial fibrillation (AF) ablation, multivalve surgery and New York Heart Association (NYHA) functional class III/IV, a recent study has found.

Bariatric surgery vs medical treatment leads to lower long-term mortality

04 Dec 2018

Long-term all-cause, cardiovascular-caused and cancer-caused mortality are lower in obese patients who have received biliopancreatic diversion (BPD) and biliointestinal bypass (BIBP) compared to those who have received nonsurgical medical weight-loss treatment, a recent study has shown.

“Malabsorptive bariatric surgery (BS) significantly reduces long-term mortality in severely obese patients,” the investigators said.

Observation period lasted for a mean 12.1±3.41 years. BS vs nonsurgical patients had reduced all-cause mortality (7.2 percent vs 12.9 percent; χ2, 11.25; p=0.001; hazard ratio [HR], 0.64; 95 percent CI, 0.43–0.93; p=0.019).

Surgery patients also had significantly less frequent cardiovascular (HR, 0.26; 0.09–0.72; p=0.003) and cancer (HR, 0.21; 0.09–0.45) causes of death compared to those on nonsurgical treatment (p<0.001).

Another aspect of the study showed that patients who underwent malabsorptive BS showed less incident cases of diabetes, cardiovascular diseases, hyperlipidaemia, oculopathy and cancer compared with controls receiving medical treatment. [Obes Surg 2018;doi:10.1007/s11695-018-3601-5]

The present study sought to analyse long-term mortality in obese patients receiving malabsorptive BS (BPD and BIBP) compared to medical treatment of obesity.

The investigators collected medical records of 1,877 obese patients (body mass index [BMI], >35 kg/m2) aged 18–65 years undergoing BS (n=472,111 with diabetes) or nonsurgical medical treatment (n=1,405,385 with diabetes), during the period 1999–2008. Nonsurgical patients were matched for age, sex, BMI and blood pressure. Life status and causes of death were determined through December 2016.

Kaplan-Meier plots and Cox regression analyses were used to compare survival across surgery and nonsurgical patients.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago

Dr Michael Lim, a senior consultant at the Paediatric Pulmonary and Sleep Division, National University Hospital, Singapore, speaks to Roshini Claire Anthony on the rare disease that is cystic fibrosis.

2 days ago
Susceptibility‐guided therapy is as effective as empiric modified bismuth quadruple therapy for the first-line treatment of Helicobacter pylori infection, with both yielding excellent eradication rates, as shown in a recent trial.
4 days ago
It appears that long-term consumption of fish and omega-3 fatty acid does not influence the risk of incident hypertension in middle-aged and older men, suggests a US study.
2 days ago
The risk factors and outcomes associated with an increased risk of permanent pacing include atrial fibrillation (AF) ablation, multivalve surgery and New York Heart Association (NYHA) functional class III/IV, a recent study has found.